Skip to main content
Erschienen in: Journal of Maxillofacial and Oral Surgery 2/2023

27.11.2021 | Original paper

Correlation of hsa miR-101-5p and hsa miR-155-3p Expression With c-Fos in Patients of Oral Submucous Fibrosis (OSMF) and Oral Squamous Cell Carcinoma (OSCC)

Erschienen in: Journal of Maxillofacial and Oral Surgery | Ausgabe 2/2023

Einloggen, um Zugang zu erhalten

Abstract

Aim

MicroRNAs have been widely acknowledged as a diagnostic, prognostic, and/or therapeutic biomarker for the progression of OSCC, but the correlation of hsa-miR-101-5p and hsa-miR-155-3p is yet to be established with c-Fos in OSCC and OSMF.

Methodology

An observational study enrolled 40 patients divided into 2 groups: Group I—21 OSMF patients without malignant transformation, Group II—19 patients with locally advanced, large-operable, or metastatic OSCC, after applying inclusion and exclusion criteria. Both miRNAs were extracted and analyzed from the tissue sample excised from the involved site. The linear regression analysis of the expression of hsa-miR-155-3p, hsa-miR-101-5p, and levels of c-fos in OSMF and OSCC patients and its correlation for habits, age, and gender were evaluated.

Results

The expression of hsa-miR-101-5p was 0.81 times downregulated in OSCC tissue compared to OSMF, whereas hsa-miR-155-3p and c-fos were both upregulated 9.30 times and 1.75 times, respectively, in OSCC tissue. In Gutkha and tobacco chewers, the hsa-miR-155-3p expression could explain 12.3% (p = 0.031) for Gutkha chewers, whereas c-fos could explain 38.6% of the cases (p = 0.020) for tobacco chewers. The expression of hsa-miR-101-5p and hsa-miR-155-3p explained 43.7% and 59.5% of OSCC cases in alcoholics, respectively. Interestingly, in non-alcoholics, hsa-miR-155-3p and hsa-miR-101-5p were significant predictors of OSCC.

Conclusion

Downregulation of tumor-suppressor hsa-miR-101-5p and upregulation of proto-onco hsa-miR-155-3p is responsible for intricate regulation of the progression of OSMF to OSCC via deregulated expression of c-Fos and tobacco chewing and advancing age is significant contributors for OSCC.
Literatur
1.
Zurück zum Zitat Bray F, Ferlay J, Soerjomataram I, Siegel RL et al (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Ca Cancer J Clin 68:394–424CrossRefPubMed Bray F, Ferlay J, Soerjomataram I, Siegel RL et al (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Ca Cancer J Clin 68:394–424CrossRefPubMed
2.
Zurück zum Zitat Chou H-C, Lin H-W, Yang J-H, Lin P-Y et al (2019) Clinical outcomes of oral cancer patients who survive for more than 5 years in Taiwan. J Formos Med Assoc 118(12):1616–1622CrossRefPubMed Chou H-C, Lin H-W, Yang J-H, Lin P-Y et al (2019) Clinical outcomes of oral cancer patients who survive for more than 5 years in Taiwan. J Formos Med Assoc 118(12):1616–1622CrossRefPubMed
3.
Zurück zum Zitat Phulari RGS, Dave EJ (2020) A systematic review on the mechanisms of malignant transformation of oral submucous fibrosis. Eur J Cancer Prev 29(5):470–473CrossRefPubMed Phulari RGS, Dave EJ (2020) A systematic review on the mechanisms of malignant transformation of oral submucous fibrosis. Eur J Cancer Prev 29(5):470–473CrossRefPubMed
4.
Zurück zum Zitat Arora R, Adwani D, Naphade M, Bhagat B, Qureshi AQ (2014) Malignant conversion of oral submucous fibrosis in surgically treated case. J Clin Diagn Res 8(10):ZD31–ZD32PubMedPubMedCentral Arora R, Adwani D, Naphade M, Bhagat B, Qureshi AQ (2014) Malignant conversion of oral submucous fibrosis in surgically treated case. J Clin Diagn Res 8(10):ZD31–ZD32PubMedPubMedCentral
5.
Zurück zum Zitat Ong TK et al (2017) Survival after surgery for oral cancer: a 30-year experience. Br J Oral Maxillofac Surg 55(9):911–916CrossRefPubMed Ong TK et al (2017) Survival after surgery for oral cancer: a 30-year experience. Br J Oral Maxillofac Surg 55(9):911–916CrossRefPubMed
6.
Zurück zum Zitat Tsai WC, Kung PT, Wang ST, Hunag KW, Liu SA (2015) Beneficial impact of multidisciplinary team management on the survival in different stages of oral cavity cancer patients: results of a nationwide cohort study in Taiwan. Oral Oncol 51(2):105–111CrossRefPubMed Tsai WC, Kung PT, Wang ST, Hunag KW, Liu SA (2015) Beneficial impact of multidisciplinary team management on the survival in different stages of oral cavity cancer patients: results of a nationwide cohort study in Taiwan. Oral Oncol 51(2):105–111CrossRefPubMed
10.
Zurück zum Zitat Wang J, Zeng H, Li H, Chen T, Wang L, Zhang K, Chen J, Wang R, Li Q, Wang S (2017) MicroRNA-101 inhibits growth, proliferation and migration and induces apoptosis of breast cancer cells by targeting sex-determining region Y-Box 2. Cell PhysiolBiochem 43:717–732. https://doi.org/10.1159/000481445CrossRef Wang J, Zeng H, Li H, Chen T, Wang L, Zhang K, Chen J, Wang R, Li Q, Wang S (2017) MicroRNA-101 inhibits growth, proliferation and migration and induces apoptosis of breast cancer cells by targeting sex-determining region Y-Box 2. Cell PhysiolBiochem 43:717–732. https://​doi.​org/​10.​1159/​000481445CrossRef
11.
Zurück zum Zitat Iorio MV, Ferracin M, Liu C-G, Veronese A, Spizzo R, Sabbioni S, Magri E, Pedriali M, Fabbri M, Campiglio M, et al. (2005) MicroRNA gene expression deregulation in human breast cancer. Cancer Res 65:7065–7070. View Article : Google Scholar : PubMed/NCBI Iorio MV, Ferracin M, Liu C-G, Veronese A, Spizzo R, Sabbioni S, Magri E, Pedriali M, Fabbri M, Campiglio M, et al. (2005) MicroRNA gene expression deregulation in human breast cancer. Cancer Res 65:7065–7070. View Article : Google Scholar : PubMed/NCBI
14.
Zurück zum Zitat Dong C, Ye DX, Zhang WB, Pan HY, Zhang ZY, Zhan L (2015) Overexpression of c-fos promotes cell invasion and migration via CD44 pathway in oral squamous cell carcinoma. J Oral Pathol Med 44:353–360CrossRefPubMed Dong C, Ye DX, Zhang WB, Pan HY, Zhang ZY, Zhan L (2015) Overexpression of c-fos promotes cell invasion and migration via CD44 pathway in oral squamous cell carcinoma. J Oral Pathol Med 44:353–360CrossRefPubMed
15.
Zurück zum Zitat Lessa AM, Valverde LF, Dias RB, Machado MCM, Santos JN, Rocha CAG (2013) The role of microRNAS in oral squamous cell carcinoma pathogenesis: a literature review. Appl Cancer Res 33(4):198–205 Lessa AM, Valverde LF, Dias RB, Machado MCM, Santos JN, Rocha CAG (2013) The role of microRNAS in oral squamous cell carcinoma pathogenesis: a literature review. Appl Cancer Res 33(4):198–205
16.
Zurück zum Zitat Buechner J, Tomte E, Haug BH, Henriksen JR, Lokke C, Flaegstad T, Einvik C (2011) Tumour-suppressor microRNAs let-7 and mir-101 target the proto-oncogene MYCN and inhibit cell proliferation in MYCN-amplified neuroblastoma. Br J Cancer 105:296–303CrossRefPubMedPubMedCentral Buechner J, Tomte E, Haug BH, Henriksen JR, Lokke C, Flaegstad T, Einvik C (2011) Tumour-suppressor microRNAs let-7 and mir-101 target the proto-oncogene MYCN and inhibit cell proliferation in MYCN-amplified neuroblastoma. Br J Cancer 105:296–303CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Zargar S, Tomar V, Shyamsundar V, Vijayalakshmi R, Somasundaram K, Karunagaran D (2019) A feedback loop between microRNA 155 (miR-155), programmed cell death 4, and activation protein 1 modulates the expression of miR-155 and tumorigenesis in tongue cancer. Mol Cell Biol 39:e00410-e418CrossRefPubMedPubMedCentral Zargar S, Tomar V, Shyamsundar V, Vijayalakshmi R, Somasundaram K, Karunagaran D (2019) A feedback loop between microRNA 155 (miR-155), programmed cell death 4, and activation protein 1 modulates the expression of miR-155 and tumorigenesis in tongue cancer. Mol Cell Biol 39:e00410-e418CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat Yin Q, Wang X, McBride J, Fewell C, Flemington E (2008) B-cell receptor activation induces BIC/miR-155 expression through a con- served AP-1 element. J Biol Chem 283:2654–2662CrossRefPubMed Yin Q, Wang X, McBride J, Fewell C, Flemington E (2008) B-cell receptor activation induces BIC/miR-155 expression through a con- served AP-1 element. J Biol Chem 283:2654–2662CrossRefPubMed
26.
Zurück zum Zitat Manikandan M, Deva Magendhra Rao AK, Arunkumar G, et al. (2016) Oral squamous cell carcinoma: microRNA expression profiling and integrative analyses for elucidation of tumourigenesis mechanism. Mol Cancer 15:28. Published 2016 Apr 7. https://doi.org/10.1186/s12943-016-0512-8 Manikandan M, Deva Magendhra Rao AK, Arunkumar G, et al. (2016) Oral squamous cell carcinoma: microRNA expression profiling and integrative analyses for elucidation of tumourigenesis mechanism. Mol Cancer 15:28. Published 2016 Apr 7. https://​doi.​org/​10.​1186/​s12943-016-0512-8
28.
Zurück zum Zitat Wang HJ, Ruan HJ, He XJ, Ma YY, Jiang XT, Xia YJ, Ye ZY, Tao HQ (2010) MicroRNA-101 is down-regulated in gastric cancer and involved in cell migration and invasion. Eur J Cancer 46:2295–2303CrossRefPubMed Wang HJ, Ruan HJ, He XJ, Ma YY, Jiang XT, Xia YJ, Ye ZY, Tao HQ (2010) MicroRNA-101 is down-regulated in gastric cancer and involved in cell migration and invasion. Eur J Cancer 46:2295–2303CrossRefPubMed
29.
Zurück zum Zitat Long Y, Wu Z, Yang X, Chen L, Han Z, Zhang Y, Liu J, Liu W, Liu X (2016) MicroRNA-101 inhibits the proliferation and invasion of bladder cancer cells via targeting c-FOS. Mol Med Rep 14:2651–2656CrossRefPubMed Long Y, Wu Z, Yang X, Chen L, Han Z, Zhang Y, Liu J, Liu W, Liu X (2016) MicroRNA-101 inhibits the proliferation and invasion of bladder cancer cells via targeting c-FOS. Mol Med Rep 14:2651–2656CrossRefPubMed
Metadaten
Titel
Correlation of hsa miR-101-5p and hsa miR-155-3p Expression With c-Fos in Patients of Oral Submucous Fibrosis (OSMF) and Oral Squamous Cell Carcinoma (OSCC)
Publikationsdatum
27.11.2021
Erschienen in
Journal of Maxillofacial and Oral Surgery / Ausgabe 2/2023
Print ISSN: 0972-8279
Elektronische ISSN: 0974-942X
DOI
https://doi.org/10.1007/s12663-021-01668-0

Weitere Artikel der Ausgabe 2/2023

Journal of Maxillofacial and Oral Surgery 2/2023 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.